Journal
JOURNAL OF NATURAL PRODUCTS
Volume 80, Issue 7, Pages 2037-2044Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.jnatprod.7b00170
Keywords
-
Funding
- Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research [1ZIA-BC01147005]
- Developmental Therapeutics Program in the Division of Cancer Treatment and Diagnosis of the National Cancer Institute
- KRIBB Research Initiative Program (Korean Biomedical Scientist Fellowship Program), Korea Research Institute of Bioscience and Biotechnology, Republic of Korea
Ask authors/readers for more resources
Bioassay-guided fractionation of a colon cancer growth inhibitory extract of the fungus Paraconiothyrium sp. led to the isolation of eight new versiol derivatives (1, 3-8, 10) along with two known compounds. The structures were elucidated by interpretation of combined MS and 2D NMR spectroscopic data. Compounds 8, 9, and 10 showed cell growth inhibition against COLO205 and KM12 cells, and both 8 and 9 displayed selectivity in their inhibition of melanoma cell lines in the NCI 60 one-dose test. In addition, compound 8 and the crude Paraconiothyrium sp. extract showed potent dose-dependent inhibitory effects in the five-dose NCI 60 cell line assay.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
